RBC Capital Reiterates Underperform on Palantir, $50 Price Target
- Rating
- Sell
- Price target
- $50
- Implied downside
- -70%
- vs $167.47 prior close
RBC Capital analyst Rishi Jaluria reiterated an Underperform rating and $50.00 price target on Palantir (NASDAQ: PLTR).
“In this note, we provide our thoughts into earnings based on our government spending tracker, checks, investor conversations, and retail themes.
We flag three themes: 1) our government data tracker points to a decline in QCV and net new ACV, while geopolitical instability could support longer demand; 2) skepticism around the durability of Commercial momentum, with recent checks suggesting customers are reassessing or moving off PLTR; and 3) a self-fulfilling prophecy risk, where Commercial momentum could persist despite durability concerns.
We view the risk/reward skewed to the downside. We also introduce our CY27 estimates.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Tracking this call
Since this note+15% PLTR $167.47 → $192.07 (Oct 7) · moving away from the target
This call at 6 months✗ Not reached in six months: PLTR closed at $123, 146% above the $50 target, but it moved the way the analyst expected.
Firm track recordRBC Capital reached 82% of its 39 scored targets within six months (#3 of 31 firms); on Palantir, 0 of 2. Accuracy ranking →
More from RBC Capital on Palantir
Other Palantir notes
StoneXHold
Kept rating · Sep 30
Goldman SachsHold
Kept rating and price target · Sep 28
$204maintained
RosenblattBuy
Kept rating and price target · Sep 23
$225maintained
UBSBuy
Raised price target +14%, kept rating · Sep 15
$250from $220
DA DavidsonBuy
Raised price target +25%, kept rating · Sep 11
$250from $200